NR1H2 and dementia: Gene expression analysis in controls and individuals with dementia (CDR ≥ 0.5) or AD-associated neuropathology showed higher levels of LXRβ gene expression (F1,84 = 3.14, p = 0.040) only in individuals with varying dementia severity (Figure 2).